Who are the leading drug innovators, and where do they live?

Leading drug inventors responsible for drugs approved over the past ten years profiled in new DrugPatentWatch report

Drug Patent Expirations in August 2010

Drug Patent Expirations in August 2010

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
ATRIPLA	Gilead	efavirenz; emtricitabine; tenofovir disoproxil fumarate	7,402,588*PED	Aug 1, 2010
TRUVADA	Gilead	emtricitabine; tenofovir disoproxil fumarate	7,402,588*PED	Aug 1, 2010
EMTRIVA	Gilead	emtricitabine	7,402,588*PED	Aug 1, 2010
GENESA	Gensia Automedics	arbutamine hydrochloride	5,234,404	Aug 10, 2010
PREVPAC	Takeda Pharms Na	amoxicillin; clarithromycin; lansoprazole	5,013,743*PED	Aug 12, 2010
PREVACID	Takeda Pharms Na	lansoprazole	5,013,743*PED	Aug 12, 2010
HECTOROL	Genzyme	doxercalciferol	5,707,980	Aug 17, 2010
NICORETTE	Glaxosmithkline Cons	nicotine polacrilex	5,110,605	Aug 21, 2010
COMMIT	Glaxosmithkline Cons	nicotine polacrilex	5,110,605	Aug 21, 2010
ZANTAC 300	Glaxosmithkline	ranitidine hydrochloride	5,028,432*PED	Aug 22, 2010
ZANTAC 150	Glaxosmithkline	ranitidine hydrochloride	5,028,432*PED	Aug 22, 2010
CAPOTEN	Par Pharm	captopril	5,238,924	Aug 24, 2010
COVERA-HS	Gd Searle Llc	verapamil hydrochloride	5,232,705	Aug 31, 2010

*Drugs may be covered by multiple patents

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com